Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Lambertini, Elisabetta ^a   Lolli, Andrea ^a   Vezzali, Federica ^a   Penolazzi, Letizia ^a   Gambari, Roberto ^a   Piva, Roberta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Breast cancer; Epithelial mesenchymal transition; miR 221; Slug

Indexed keywords

ANTAGOMIR; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; MICRORNA 221; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; ER ALPHA GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLUG GENE; TRANSCRIPTION INITIATION; TRPS1 GENE; WESTERN BLOTTING; WOUND HEALING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84866788059     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-445     Document Type: Article

References (50)

1. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011, 27:347-376. 10.1146/annurev-cellbio-092910-154036, 21740232.
2. Vincent-Salomon A, Thiery JP. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 2003, 5(2):101-106. 10.1186/bcr578, 154156, 12631389.
3. De Herreros AG, Peiró S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010, 15(2):135-147. 10.1007/s10911-010-9179-8, 2930904, 20455012.
4. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132(14):3151-3161. 10.1242/dev.01907, 15983400.
5. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139(5):871-890. 10.1016/j.cell.2009.11.007, 19945376.
6. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7(20):3112-3118. 10.4161/cc.7.20.6851, 18927505.
7. Guttilla IK, Adams BD, White BA. ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol Metab 2012, 23(2):73-82. 10.1016/j.tem.2011.12.001, 22257677.
8. Wright JA, Richer JK, Goodall GJ. microRNAs and EMT in mammary cells and breast cancer. J Mammary Gland Biol Neoplasia 2010, 15(2):213-223. 10.1007/s10911-010-9183-z, 20499142.
9. Howe EN, Cochrane DR, Richer JK. The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia 2012, 17(1):65-77. 10.1007/s10911-012-9244-6, 22350980.
10. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9(6):582-589. 10.1038/embor.2008.74, 2396950, 18483486.
11. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, Zr Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T. The EMT activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009, 11(12):1487-1495. 10.1038/ncb1998, 19935649.
12. Reshmi G, Sona C, Pillai MR. Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis. J Cell Biochem 2011, 112(9):2210-2217. 10.1002/jcb.23148, 21503963.
13. Wang J, Haubrock M, Cao KM, Hua X, Zhang CY, Wingender E, Li J. Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol 2011, 5:199. 10.1186/1752-0509-5-199, 3262773, 22176772.
14. Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One 2012, 7(4):e35440. 10.1371/journal.pone.0035440, 3325969, 22514743.
15. Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K. MiR-1 and miR-200 inhibit EMT via slug-dependent and tumorigenesis via slug-independent mechanisms. Oncogene 2012, in press.
16. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011, 208(5):875-883. 10.1084/jem.20110235, 3092351, 21518799.
17. Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal 2011, 4(177):ra41. 10.1126/scisignal.2001538, 21673316.
18. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 2011, 195(3):417-433. 10.1083/jcb.201103097, 3206336, 22024162.
19. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68(19):7846-7854. 10.1158/0008-5472.CAN-08-1942, 18829540.
20. Shah MY, Calin GA. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 2011, 3(8):56. 10.1186/gm272, 3238182, 21888691.
21. Mancini M, Petta S, Iacobucci I, Salvestrini V, Barbieri E, Santucci MA. Zinc finger transcription factor slug contributes tothe survival advantage of chronic myeloid leukemia cells. Cell Signal 2010, 22(8):1247-1253. 10.1016/j.cellsig.2010.04.002, 20388540.
22. Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res 2007, 25(7):964-971. 10.1002/jor.20356, 17318900.
23. Jethwa P, Naqvi M, Hardy RG, Hotchin NA, Roberts S, Spychal R, Tselepis C. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 2008, 14(7):1044-1052. 10.3748/wjg.14.1044, 2689407, 18286686.
24. Côme C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 2006, 12(18):5395-5402. 10.1158/1078-0432.CCR-06-0478, 17000672.
25. Vitali R, Mancini C, Cesi V, Tanno B, Mancuso M, Bossi G, Zhang Y, Martinez RV, Calabretta B, Dominici C, Raschellà G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasivegrowth in neuroblastoma preclinical models. Clin Cancer Res 2008, 14(14):4622-4630. 10.1158/1078-0432.CCR-07-5210, 18628477.
26. Howard EW, Camm KD, Wong YC, Wang XH. E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Rev Med Chem 2008, 8(5):496-518. 10.2174/138955708784223521, 18473938.
27. Mimeault M, Batra SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev 2007, 26(1):203-214. 10.1007/s10555-007-9052-4, 17273942.
28. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 2007, 13(16):4769-4776. 10.1158/1078-0432.CCR-06-2926, 17699854.
29. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007, 282(32):23716-23724. 10.1074/jbc.M701805200, 17569667.
30. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010, 107(1):264-269. 10.1073/pnas.0907904107, 2806773, 20018759.
31. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008, 68(8):2745-2754. 10.1158/0008-5472.CAN-07-2538, 18417445.
32. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 2010, 102(10):706-721. 10.1093/jnci/djq102, 2873185, 20388878.
33. Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP. MicroRNA221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011, 30(9):1082-1097. 10.1038/onc.2010.487, 3342929, 21057537.
34. Zhao R, Wu J, Jia W, Gong C, Yu F, Ren Z, Chen K, He J, Su F. Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie 2011, 34(12):675-680. 10.1159/000334552, 22156446.
35. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Barsky SH. ERalpha suppresses slug expression directly by transcriptional repression. Biochem J 2008, 416(2):179-187. 10.1042/BJ20080328, 2584332, 18588516.
36. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH. ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene 2010, 29(10):1451-1462. 10.1038/onc.2009.433, 20101232.
37. Dhasarathy A, Kajita M, Wade PA. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 2007, 21(12):2907-2918. 10.1210/me.2007-0293, 2668600, 17761946.
38. Torreggiani E, Lisignoli G, Manferdini C, Lambertini E, Penolazzi L, Vecchiatini R, Gabusi E, Chieco P, Facchini A, Gambari R, Piva R. Role of Slug transcription factor in human mesenchymal stem cells. J Cell Mol Med 2012, 16(4):740-751. 10.1111/j.1582-4934.2011.01352.x, 21645238.
39. Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A, Piva R. Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci 2009, 66(22):3641-3653. 10.1007/s00018-009-0149-5, 19756381.
40. Penolazzi L, Tavanti E, Vecchiatini R, Lambertini E, Vesce F, Gambari R, Mazzitelli S, Mancuso F, Luca G, Nastruzzi C, Piva R. Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeads. Tissue Eng Part C Methods 2010, 16(1):141-155. 10.1089/ten.tec.2008.0582, 19402785.
41. Chen Y, Gelfond J, McManus LM, Shireman PK. Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol Genomics 2011, 43(10):621-630. 10.1152/physiolgenomics.00136.2010, 3110887, 20841498.
42. Ciaudo C, Servant N, Cognat V, Sarazin A, Kieffer E, Viville S, Colot V, Barillot E, Heard E, Voinnet O. Highly dynamic and sex-specific expression of microRNAs during early ES cell differentiation. PLoS Genet 2009, 5(8):e1000620. 10.1371/journal.pgen.1000620, 2725319, 19714213.
43. Cailleau R, Olivé M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978, 14(11):911-915. 10.1007/BF02616120, 730202.
44. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997, 119(2):149-155. 10.1016/S0304-3835(97)00273-5, 9570365.
45. Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 2009, 384(1):6-11. 10.1016/j.bbrc.2009.04.051, 2700729, 19379710.
46. Kajita M, McClinic KN, Wade PA. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004, 24(17):7559-7566. 10.1128/MCB.24.17.7559-7566.2004, 506998, 15314165.
47. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30(12):1436-1448. 10.1038/onc.2010.509, 21057535.
48. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62(6):1613-1618.
49. Sakai D, Suzuki T, Osumi N, Wakamatsu Y. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133(7):1323-1333. 10.1242/dev.02297, 16510505.
50. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008, 283(45):31079-31086. 10.1074/jbc.M806041200, 2576549, 18790736.